Zealand Pharma A/S. Profit Margin

Zealand Pharma A/S. posts a profit margin of -497.08% as of March 2022. That compares with -239.68% in the prior-year period — down 107.4% year over year. That is below the Healthcare sector average of 13.89%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Zealand Pharma A/S.'s profit margin was -239.68%. The latest reading is -497.08% — a 107.4% year-over-year decrease (period ending March 2022). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 13.89% is typical. Zealand Pharma A/S.'s -497.08% is lower that level. That is roughly 3677.9% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Zealand Pharma A/S.'s profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -497.08% as of March 2022; use YoY and peer views to separate noise from signal.

Context for ZEAL's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.89%), and (3) consistency with growth and profitability. This page covers the first two; Zealand Pharma A/S.'s other metric pages and overview cover the third.